Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
Meetings
Meetings
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
WCLC 2016 Together Against Lung Cancer
lungcanc
IASLC World Conference on Lung Cancer 2016 Together Against Lung Cancer
2019 IASLC World Conference on Lung Cancer Updates
Highlights from IASLC WCLC 2016
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
lungcanc
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
lungcanc
Lung Cancer 360 Forum Overview: C.A.I.R.O Journal Club’s Fourth Anniversary
lungcanc
First School of Nursing to Be Held at 2019 Latin American...
lungcanc
7th IASLC Latin American Conference on Lung Cancer
lungcanc
The Long Road Home
lungcanc
The IASLC’s Spotlight on Screening
lungcanc
IASLC’s Inaugural Mesothelioma Meeting Sets Baseline for Strategic Approach to Patient...
lungcanc
IASLC Workshop in Lung Cancer Clinical Research
lungcanc
Bronchoscopy Ultrasound and Navigational Bronchoscopy Finally Arrive in Peru
lungcanc
1
2
3
...
6
Page 1 of 6
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS